BR112012030117A2 - pluralidade de composições, uso da mesma e método para a prevenção ou tratamento de doença cardiovascular, diabetes do tipo 2, inflamação, diarréia e saúde óssea - Google Patents
pluralidade de composições, uso da mesma e método para a prevenção ou tratamento de doença cardiovascular, diabetes do tipo 2, inflamação, diarréia e saúde ósseaInfo
- Publication number
- BR112012030117A2 BR112012030117A2 BR112012030117A BR112012030117A BR112012030117A2 BR 112012030117 A2 BR112012030117 A2 BR 112012030117A2 BR 112012030117 A BR112012030117 A BR 112012030117A BR 112012030117 A BR112012030117 A BR 112012030117A BR 112012030117 A2 BR112012030117 A2 BR 112012030117A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- over
- diarrhea
- inflammation
- prevention
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 3
- 206010012735 Diarrhoea Diseases 0.000 title abstract 3
- 206010061218 Inflammation Diseases 0.000 title abstract 3
- 230000004054 inflammatory process Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- 230000037180 bone health Effects 0.000 title abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
- 230000037213 diet Effects 0.000 abstract 3
- 235000005911 diet Nutrition 0.000 abstract 3
- 235000013305 food Nutrition 0.000 abstract 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 abstract 2
- 230000036541 health Effects 0.000 abstract 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- 229940074391 gallic acid Drugs 0.000 abstract 1
- 235000004515 gallic acid Nutrition 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract 1
- 235000013824 polyphenols Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Pediatric Medicine (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10164261 | 2010-05-28 | ||
| PCT/EP2011/058537 WO2011147862A1 (en) | 2010-05-28 | 2011-05-25 | Compositions for dietary health management |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012030117A2 true BR112012030117A2 (pt) | 2017-05-16 |
Family
ID=43422235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012030117A BR112012030117A2 (pt) | 2010-05-28 | 2011-05-25 | pluralidade de composições, uso da mesma e método para a prevenção ou tratamento de doença cardiovascular, diabetes do tipo 2, inflamação, diarréia e saúde óssea |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9451785B2 (https=) |
| EP (1) | EP2575500B1 (https=) |
| CN (1) | CN102970882B (https=) |
| BR (1) | BR112012030117A2 (https=) |
| IN (1) | IN2012MN02476A (https=) |
| WO (1) | WO2011147862A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2852032A1 (en) * | 2011-11-29 | 2013-06-06 | Unilever Plc | A meal intended for human consumption |
| KR101618969B1 (ko) | 2014-08-26 | 2016-05-09 | 원광대학교산학협력단 | 파골세포 분화 및 생성 억제 효과를 갖는 화합물을 함유하는 약학적 조성물 |
| KR101797454B1 (ko) | 2016-07-06 | 2017-11-15 | 원광대학교산학협력단 | 시아니딘-3-글루코시드 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 골형성 촉진용 약학적 조성물 |
| CN111096972B (zh) * | 2020-02-25 | 2023-07-14 | 成都医学院 | 一种预防和/或治疗阿尔茨海默症的药物组合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2223102A1 (en) | 1995-06-06 | 1996-12-12 | Campbell Soup Company | Therapeutic system for dietary health management |
| US6039989A (en) | 1995-06-06 | 2000-03-21 | Campbell Soup Company | Prepackaged therapeutic meal for treatment of diet-responsive conditions |
| EP0833571A2 (en) | 1995-06-06 | 1998-04-08 | Campbell Soup Company | Compliance support package for increasing health management system compliance |
| US6352712B1 (en) | 1999-04-30 | 2002-03-05 | Daniel O. Lukaczer | Dietary supplements for treating fatigue-related syndromes |
| WO2002011562A2 (en) * | 2000-08-08 | 2002-02-14 | Advanced Functional Foods International, Inc. | Nutritional supplement for the management of weight |
| US6808727B2 (en) | 2001-07-20 | 2004-10-26 | Emanuel S. Kemeny | Meal-equivalent food bar |
| US20030206982A1 (en) | 2002-04-24 | 2003-11-06 | Antje Spors | Method of improving dietary balance using gustatory and olfactory aliesthesia |
| JP2004242586A (ja) | 2003-02-14 | 2004-09-02 | Eifuji:Kk | 加工食品、加工食品の副合製品又はジュース類の製造方法 |
| CA2577984C (en) | 2004-08-25 | 2012-01-24 | Regents Of The University Of Minnesota | Compositions and methods to lower glycohemoglobin levels |
| CN101305802B (zh) | 2008-07-07 | 2014-03-12 | 杭州名博健康管理有限公司 | 饮食干预产品 |
-
2011
- 2011-05-25 BR BR112012030117A patent/BR112012030117A2/pt not_active IP Right Cessation
- 2011-05-25 US US13/698,685 patent/US9451785B2/en not_active Expired - Fee Related
- 2011-05-25 IN IN2476MUN2012 patent/IN2012MN02476A/en unknown
- 2011-05-25 EP EP11721324.9A patent/EP2575500B1/en not_active Not-in-force
- 2011-05-25 WO PCT/EP2011/058537 patent/WO2011147862A1/en not_active Ceased
- 2011-05-25 CN CN201180026011.1A patent/CN102970882B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2575500B1 (en) | 2014-05-14 |
| IN2012MN02476A (https=) | 2015-06-12 |
| WO2011147862A1 (en) | 2011-12-01 |
| EP2575500A1 (en) | 2013-04-10 |
| CN102970882B (zh) | 2015-07-22 |
| US9451785B2 (en) | 2016-09-27 |
| CN102970882A (zh) | 2013-03-13 |
| US20140057843A1 (en) | 2014-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Advances in nutritional supplementation for sarcopenia management | |
| Gualano et al. | In sickness and in health: the widespread application of creatine supplementation | |
| Tavafzadeh et al. | Bone mechanical properties and mineral density in response to cessation of jumping exercise and honey supplementation in young female rats | |
| Parcell | Sulfur in human nutrition and applications in medicine | |
| Bloomer | The role of nutritional supplements in the prevention and treatment of resistance exercise-induced skeletal muscle injury | |
| Xie et al. | Caloric restriction: implications for sarcopenia and potential mechanisms | |
| Pinheiro et al. | Metabolic and functional effects of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in skeletal muscle | |
| BR112012002639A2 (pt) | métodos e composições para melhorar a saude gastrintestinal | |
| BR112012033422B8 (pt) | formulação de alimentação por sonda de alimentação diária completa, seu uso e seu método de fabricação | |
| BRPI0821005A8 (pt) | Método para aumentar a eficiência da absorção de xantofilas e composição | |
| BR112014009097A2 (pt) | composição para uso na promoção de crescimento de osso saudável e/ou na prevenção e/ou tratamento das doenças dos ossos | |
| US12029762B2 (en) | Alkalized organic pharmaceutical or nutraceutical composition | |
| Hewlings et al. | Sulfur in human health | |
| BR112012030117A2 (pt) | pluralidade de composições, uso da mesma e método para a prevenção ou tratamento de doença cardiovascular, diabetes do tipo 2, inflamação, diarréia e saúde óssea | |
| MX347021B (es) | Composiciones para tratar disfunción eréctil. | |
| Yu et al. | LPS-related muscle loss is associated with the alteration of Bacteroidetes abundance, systemic inflammation, and mitochondrial morphology in a weaned piglet model | |
| WO2016072992A1 (en) | Nutraceutical supplement with lactobacillus rhamnosus | |
| BR112014003445A2 (pt) | métodos para melhora de sintomas ou condições causadas por estresse | |
| Sakkas et al. | Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting? | |
| Alalwan | Nutraceuticals and their role in promoting musculoskeletal healthy aging. | |
| Lynch | Identifying the challenges for successful pharmacotherapeutic management of sarcopenia | |
| Ahmad et al. | Relative efficacy of piracetam, modafinil and citicoline on cognitive function in an animal model | |
| Novita et al. | Effect of anthocyanin to post-orthodontic treatment: A review | |
| CN103169695B (zh) | α-硫辛酸,乙酰左旋肉碱,辅酶Q10及羟基酪醇配伍在防治肌萎缩发生中的应用 | |
| BRPI1002720B8 (pt) | uso de um extrato vegetal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15K | Others concerning applications: alteration of classification |
Ipc: A23L 33/105 (2016.01), A23L 33/00 (2016.01), A23L |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2622 DE 06-04-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |